nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—SHBG—hindbrain—Parkinson's disease	0.016	0.0486	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—head—Parkinson's disease	0.016	0.0486	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—nervous system—Parkinson's disease	0.0152	0.046	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—central nervous system—Parkinson's disease	0.0146	0.0443	CbGeAlD
Medroxyprogesterone Acetate—PGR—hindbrain—Parkinson's disease	0.0144	0.0438	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—brain—Parkinson's disease	0.0116	0.0352	CbGeAlD
Medroxyprogesterone Acetate—ESR1—hindbrain—Parkinson's disease	0.0113	0.0343	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—nerve—Parkinson's disease	0.0111	0.0338	CbGeAlD
Medroxyprogesterone Acetate—SHBG—brainstem—Parkinson's disease	0.00918	0.0279	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—medulla oblongata—Parkinson's disease	0.00852	0.0259	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—hindbrain—Parkinson's disease	0.00833	0.0253	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—midbrain—Parkinson's disease	0.00779	0.0236	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—spinal cord—Parkinson's disease	0.0076	0.0231	CbGeAlD
Medroxyprogesterone Acetate—SHBG—cardiovascular system—Parkinson's disease	0.00749	0.0227	CbGeAlD
Medroxyprogesterone Acetate—ESR1—embryo—Parkinson's disease	0.00706	0.0214	CbGeAlD
Medroxyprogesterone Acetate—PGR—cardiovascular system—Parkinson's disease	0.00675	0.0205	CbGeAlD
Medroxyprogesterone Acetate—Testosterone Propionate—COMT—Parkinson's disease	0.00649	0.38	CrCbGaD
Medroxyprogesterone Acetate—ESR1—brainstem—Parkinson's disease	0.00647	0.0196	CbGeAlD
Medroxyprogesterone Acetate—AR—forebrain—Parkinson's disease	0.00636	0.0193	CbGeAlD
Medroxyprogesterone Acetate—ESR1—forebrain—Parkinson's disease	0.00624	0.019	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—cerebellum—Parkinson's disease	0.00602	0.0183	CbGeAlD
Medroxyprogesterone Acetate—AR—cardiovascular system—Parkinson's disease	0.00538	0.0163	CbGeAlD
Medroxyprogesterone Acetate—ESR1—cardiovascular system—Parkinson's disease	0.00528	0.016	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—embryo—Parkinson's disease	0.00521	0.0158	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—brain—Parkinson's disease	0.00489	0.0149	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—brainstem—Parkinson's disease	0.00477	0.0145	CbGeAlD
Medroxyprogesterone Acetate—SHBG—central nervous system—Parkinson's disease	0.00463	0.0141	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—forebrain—Parkinson's disease	0.00461	0.014	CbGeAlD
Medroxyprogesterone Acetate—PGR—head—Parkinson's disease	0.00457	0.0139	CbGeAlD
Medroxyprogesterone Acetate—SHBG—cerebellum—Parkinson's disease	0.00453	0.0137	CbGeAlD
Medroxyprogesterone Acetate—PGR—nervous system—Parkinson's disease	0.00433	0.0132	CbGeAlD
Medroxyprogesterone Acetate—PGR—central nervous system—Parkinson's disease	0.00417	0.0127	CbGeAlD
Medroxyprogesterone Acetate—AR—spinal cord—Parkinson's disease	0.0041	0.0124	CbGeAlD
Medroxyprogesterone Acetate—PGR—cerebellum—Parkinson's disease	0.00408	0.0124	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—cardiovascular system—Parkinson's disease	0.0039	0.0118	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—cardiovascular system—Parkinson's disease	0.00386	0.0117	CbGeAlD
Medroxyprogesterone Acetate—SHBG—brain—Parkinson's disease	0.00368	0.0112	CbGeAlD
Medroxyprogesterone Acetate—AR—head—Parkinson's disease	0.00364	0.0111	CbGeAlD
Medroxyprogesterone Acetate—ESR1—head—Parkinson's disease	0.00358	0.0109	CbGeAlD
Medroxyprogesterone Acetate—AR—nervous system—Parkinson's disease	0.00345	0.0105	CbGeAlD
Medroxyprogesterone Acetate—ESR1—nervous system—Parkinson's disease	0.00339	0.0103	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—medulla oblongata—Parkinson's disease	0.00333	0.0101	CbGeAlD
Medroxyprogesterone Acetate—AR—central nervous system—Parkinson's disease	0.00332	0.0101	CbGeAlD
Medroxyprogesterone Acetate—PGR—brain—Parkinson's disease	0.00331	0.0101	CbGeAlD
Medroxyprogesterone Acetate—ESR1—central nervous system—Parkinson's disease	0.00326	0.00991	CbGeAlD
Medroxyprogesterone Acetate—ESR1—cerebellum—Parkinson's disease	0.00319	0.00968	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—midbrain—Parkinson's disease	0.00304	0.00923	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—spinal cord—Parkinson's disease	0.00297	0.00901	CbGeAlD
Medroxyprogesterone Acetate—AR—brain—Parkinson's disease	0.00264	0.00801	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—head—Parkinson's disease	0.00264	0.00801	CbGeAlD
Medroxyprogesterone Acetate—ESR1—brain—Parkinson's disease	0.00259	0.00787	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—nervous system—Parkinson's disease	0.0025	0.00759	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—central nervous system—Parkinson's disease	0.00241	0.00731	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—cerebellum—Parkinson's disease	0.00235	0.00714	CbGeAlD
Medroxyprogesterone Acetate—Megestrol acetate—ABCB1—Parkinson's disease	0.00216	0.126	CrCbGaD
Medroxyprogesterone Acetate—CYP2C8—brain—Parkinson's disease	0.00213	0.00648	CbGeAlD
Medroxyprogesterone Acetate—Testosterone—MAOA—Parkinson's disease	0.00212	0.124	CrCbGaD
Medroxyprogesterone Acetate—NR3C1—brain—Parkinson's disease	0.00191	0.0058	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—nervous system—Parkinson's disease	0.00189	0.00574	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—central nervous system—Parkinson's disease	0.00182	0.00553	CbGeAlD
Medroxyprogesterone Acetate—Methylprednisolone—ABCB1—Parkinson's disease	0.00165	0.0968	CrCbGaD
Medroxyprogesterone Acetate—Spironolactone—ABCB1—Parkinson's disease	0.00134	0.0786	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—CYP2D6—Parkinson's disease	0.00102	0.0596	CrCbGaD
Medroxyprogesterone Acetate—Hydrocortisone—ABCB1—Parkinson's disease	0.000892	0.0522	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—ABCB1—Parkinson's disease	0.000727	0.0425	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—ABCB1—Parkinson's disease	0.000687	0.0402	CrCbGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000431	0.000659	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HSPA1A—Parkinson's disease	0.000429	0.000656	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000419	0.000641	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000418	0.00064	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—RPL6—Parkinson's disease	0.000414	0.000634	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—FGF20—Parkinson's disease	0.000411	0.00063	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—Parkinson's disease	0.00041	0.000628	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—RPL6—Parkinson's disease	0.000408	0.000625	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—RPL14—Parkinson's disease	0.000408	0.000624	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—RPL23A—Parkinson's disease	0.000408	0.000624	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000405	0.00062	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000404	0.000618	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.000403	0.000616	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000401	0.000613	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—HSPA8—Parkinson's disease	0.0004	0.000612	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.0004	0.000612	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CYP2D6—Parkinson's disease	0.0004	0.000612	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ADORA2A—Parkinson's disease	0.000399	0.000611	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—CTGF—Parkinson's disease	0.000398	0.000609	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PDYN—Parkinson's disease	0.000398	0.000609	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000398	0.000609	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—DGKQ—Parkinson's disease	0.000396	0.000607	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GPR37—Parkinson's disease	0.000396	0.000607	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—INS—Parkinson's disease	0.000394	0.000604	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CTGF—Parkinson's disease	0.000392	0.000601	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—RPS8—Parkinson's disease	0.00038	0.000582	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GFAP—Parkinson's disease	0.000374	0.000573	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000371	0.000567	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GRM5—Parkinson's disease	0.00037	0.000566	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—INSR—Parkinson's disease	0.000368	0.000563	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000366	0.00056	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CYP2E1—Parkinson's disease	0.000366	0.00056	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—HSPA1A—Parkinson's disease	0.000364	0.000557	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000363	0.000555	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—NQO1—Parkinson's disease	0.000362	0.000553	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000361	0.000553	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—TH—Parkinson's disease	0.000356	0.000545	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000353	0.00054	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TNF—Parkinson's disease	0.000352	0.000538	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000348	0.000533	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—FGB—Parkinson's disease	0.000348	0.000533	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HTR1A—Parkinson's disease	0.000346	0.00053	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000343	0.000525	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CYCS—Parkinson's disease	0.000342	0.000524	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TAC1—Parkinson's disease	0.000341	0.000522	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000341	0.000522	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—DRD1—Parkinson's disease	0.000334	0.000512	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000332	0.000508	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FGF20—Parkinson's disease	0.000325	0.000497	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—DRD3—Parkinson's disease	0.000324	0.000496	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000323	0.000495	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ND3—Parkinson's disease	0.000323	0.000494	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MCCC1—Parkinson's disease	0.000323	0.000494	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000323	0.000494	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000318	0.000487	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RIT2—Parkinson's disease	0.000317	0.000485	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ADORA2A—Parkinson's disease	0.000315	0.000482	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—RPL14—Parkinson's disease	0.000314	0.000481	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—RPL23A—Parkinson's disease	0.000314	0.000481	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—RPL23A—Parkinson's disease	0.000309	0.000473	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—RPL14—Parkinson's disease	0.000309	0.000473	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—HSPA8—Parkinson's disease	0.000305	0.000466	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000304	0.000465	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TALDO1—Parkinson's disease	0.000304	0.000465	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—OMD—Parkinson's disease	0.000304	0.000465	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—CTGF—Parkinson's disease	0.000303	0.000464	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—COMT—Parkinson's disease	0.000303	0.000464	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ADRBK1—Parkinson's disease	0.000302	0.000463	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GSTP1—Parkinson's disease	0.000302	0.000462	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—MAOA—Parkinson's disease	0.000301	0.00046	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GRK5—Parkinson's disease	0.0003	0.00046	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—HMOX1—Parkinson's disease	0.000297	0.000455	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—RPS8—Parkinson's disease	0.000293	0.000448	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HTR7—Parkinson's disease	0.000293	0.000448	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—DRD2—Parkinson's disease	0.000293	0.000448	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MTHFR—Parkinson's disease	0.000292	0.000448	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—INSR—Parkinson's disease	0.00029	0.000444	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—RPS8—Parkinson's disease	0.000289	0.000442	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NDUFB11—Parkinson's disease	0.000288	0.000441	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ABCB1—Parkinson's disease	0.000285	0.000437	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—IL6—Parkinson's disease	0.000284	0.000434	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000279	0.000427	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—HSPA1A—Parkinson's disease	0.000277	0.000425	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GSTM1—Parkinson's disease	0.000277	0.000424	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GCH1—Parkinson's disease	0.000275	0.00042	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FGB—Parkinson's disease	0.000274	0.00042	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HTR1A—Parkinson's disease	0.000273	0.000418	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—APOE—Parkinson's disease	0.000272	0.000417	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GRM4—Parkinson's disease	0.000269	0.000412	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TAC1—Parkinson's disease	0.000269	0.000412	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000267	0.000409	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000266	0.000407	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000266	0.000406	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GPX1—Parkinson's disease	0.000265	0.000406	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000264	0.000404	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—DRD1—Parkinson's disease	0.000264	0.000404	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ND3—Parkinson's disease	0.000263	0.000402	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MCCC1—Parkinson's disease	0.000263	0.000402	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000263	0.000402	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000262	0.000402	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAG—Parkinson's disease	0.000255	0.000391	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PENK—Parkinson's disease	0.000255	0.000391	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—DRD3—Parkinson's disease	0.000255	0.000391	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—IL6—Parkinson's disease	0.000254	0.000389	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000248	0.000379	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TALDO1—Parkinson's disease	0.000247	0.000378	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—OMD—Parkinson's disease	0.000247	0.000378	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IGF2—Parkinson's disease	0.000245	0.000376	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000245	0.000376	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—MTHFR—Parkinson's disease	0.000245	0.000375	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—DBH—Parkinson's disease	0.000245	0.000375	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—FBP1—Parkinson's disease	0.000245	0.000375	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GBA—Parkinson's disease	0.000245	0.000375	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000245	0.000374	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000241	0.000369	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ADRBK1—Parkinson's disease	0.000239	0.000365	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IGF1R—Parkinson's disease	0.000237	0.000363	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—HSPA8—Parkinson's disease	0.000235	0.000359	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EDN1—Parkinson's disease	0.000234	0.000359	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	0.000234	0.000359	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—CTGF—Parkinson's disease	0.000234	0.000358	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PDYN—Parkinson's disease	0.000234	0.000358	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—INS—Parkinson's disease	0.000233	0.000356	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—HSPA8—Parkinson's disease	0.000231	0.000354	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—DRD2—Parkinson's disease	0.000231	0.000353	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HTR7—Parkinson's disease	0.000231	0.000353	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—CTGF—Parkinson's disease	0.00023	0.000352	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—APOE—Parkinson's disease	0.000228	0.000349	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GCH1—Parkinson's disease	0.000224	0.000342	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GFAP—Parkinson's disease	0.00022	0.000336	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GRM5—Parkinson's disease	0.000217	0.000332	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NGF—Parkinson's disease	0.000215	0.00033	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—HSPA1A—Parkinson's disease	0.000214	0.000327	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—HSPA1A—Parkinson's disease	0.00021	0.000322	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HTR2A—Parkinson's disease	0.000205	0.000314	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000202	0.000309	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GBA—Parkinson's disease	0.000199	0.000305	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—FBP1—Parkinson's disease	0.000199	0.000305	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—DBH—Parkinson's disease	0.000199	0.000305	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—INS—Parkinson's disease	0.000195	0.000298	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IGF2—Parkinson's disease	0.000194	0.000296	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—APOE—Parkinson's disease	0.000191	0.000292	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FGF20—Parkinson's disease	0.00019	0.000291	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IGF1R—Parkinson's disease	0.000187	0.000286	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EDN1—Parkinson's disease	0.000185	0.000283	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000185	0.000283	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—DDC—Parkinson's disease	0.00018	0.000275	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000173	0.000265	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000173	0.000265	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—INSR—Parkinson's disease	0.00017	0.000261	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NGF—Parkinson's disease	0.00017	0.00026	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTA4—Parkinson's disease	0.00017	0.00026	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000168	0.000256	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000163	0.000249	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000163	0.000249	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—INS—Parkinson's disease	0.000163	0.000249	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HTR2A—Parkinson's disease	0.000162	0.000248	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FGB—Parkinson's disease	0.000161	0.000247	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR1A—Parkinson's disease	0.00016	0.000245	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TAC1—Parkinson's disease	0.000158	0.000242	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—DRD1—Parkinson's disease	0.000155	0.000237	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000155	0.000237	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	0.000153	0.000234	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MAOB—Parkinson's disease	0.000151	0.000231	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—APOE—Parkinson's disease	0.00015	0.00023	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—DRD3—Parkinson's disease	0.00015	0.000229	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000147	0.000226	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—DDC—Parkinson's disease	0.000146	0.000224	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000144	0.00022	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ADRBK1—Parkinson's disease	0.00014	0.000214	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTA4—Parkinson's disease	0.000138	0.000211	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000136	0.000209	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR7—Parkinson's disease	0.000136	0.000207	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—DRD2—Parkinson's disease	0.000136	0.000207	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000131	0.000201	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000131	0.000201	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000131	0.000201	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—INS—Parkinson's disease	0.000128	0.000197	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	0.000124	0.00019	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MAOB—Parkinson's disease	0.000123	0.000188	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CASP3—Parkinson's disease	0.000121	0.000186	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000117	0.000179	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF2—Parkinson's disease	0.000114	0.000174	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	0.000112	0.000172	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MAPK8—Parkinson's disease	0.000111	0.000171	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CTGF—Parkinson's disease	0.00011	0.000169	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF1R—Parkinson's disease	0.00011	0.000168	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EDN1—Parkinson's disease	0.000109	0.000166	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	0.000103	0.000157	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NQO1—Parkinson's disease	0.000102	0.000156	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6—Parkinson's disease	0.000102	0.000156	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TH—Parkinson's disease	0.0001	0.000153	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NGF—Parkinson's disease	9.97e-05	0.000153	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—DDC—Parkinson's disease	9.65e-05	0.000148	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYCS—Parkinson's disease	9.62e-05	0.000147	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CASP3—Parkinson's disease	9.57e-05	0.000146	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR2A—Parkinson's disease	9.49e-05	0.000145	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	9.15e-05	0.00014	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTA4—Parkinson's disease	9.11e-05	0.000139	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CTGF—Parkinson's disease	8.98e-05	0.000137	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOE—Parkinson's disease	8.83e-05	0.000135	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MAPK8—Parkinson's disease	8.79e-05	0.000135	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—COMT—Parkinson's disease	8.52e-05	0.00013	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTP1—Parkinson's disease	8.48e-05	0.00013	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MAOA—Parkinson's disease	8.46e-05	0.000129	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	8.37e-05	0.000128	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—HMOX1—Parkinson's disease	8.36e-05	0.000128	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NQO1—Parkinson's disease	8.27e-05	0.000127	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	8.2e-05	0.000126	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TH—Parkinson's disease	8.15e-05	0.000125	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MAOB—Parkinson's disease	8.12e-05	0.000124	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ABCB1—Parkinson's disease	8.03e-05	0.000123	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYCS—Parkinson's disease	7.83e-05	0.00012	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTM1—Parkinson's disease	7.79e-05	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—INS—Parkinson's disease	7.54e-05	0.000115	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GPX1—Parkinson's disease	7.46e-05	0.000114	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6—Parkinson's disease	7.12e-05	0.000109	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—COMT—Parkinson's disease	6.93e-05	0.000106	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTP1—Parkinson's disease	6.9e-05	0.000106	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MTHFR—Parkinson's disease	6.89e-05	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MAOA—Parkinson's disease	6.88e-05	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HMOX1—Parkinson's disease	6.81e-05	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ABCB1—Parkinson's disease	6.53e-05	0.0001	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOE—Parkinson's disease	6.41e-05	9.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTM1—Parkinson's disease	6.34e-05	9.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GPX1—Parkinson's disease	6.07e-05	9.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	6.03e-05	9.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CTGF—Parkinson's disease	5.92e-05	9.06e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CASP3—Parkinson's disease	5.61e-05	8.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6—Parkinson's disease	5.61e-05	8.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MTHFR—Parkinson's disease	5.6e-05	8.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	5.52e-05	8.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—INS—Parkinson's disease	5.48e-05	8.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NQO1—Parkinson's disease	5.46e-05	8.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TH—Parkinson's disease	5.38e-05	8.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOE—Parkinson's disease	5.22e-05	7.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYCS—Parkinson's disease	5.16e-05	7.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAPK8—Parkinson's disease	5.16e-05	7.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—COMT—Parkinson's disease	4.57e-05	7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.55e-05	6.96e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.54e-05	6.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.49e-05	6.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—INS—Parkinson's disease	4.46e-05	6.82e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ABCB1—Parkinson's disease	4.31e-05	6.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.18e-05	6.4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GPX1—Parkinson's disease	4.01e-05	6.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.7e-05	5.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOE—Parkinson's disease	3.44e-05	5.27e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6—Parkinson's disease	3.3e-05	5.04e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—INS—Parkinson's disease	2.94e-05	4.5e-05	CbGpPWpGaD
